Estonia National Biobank Selects PacBio to Sequence 10,000 Whole Genomes
March 28, 2024
HiFi Data Generated on the Revio™ System will Support the EU and Estonian Government-Funded Center for Personalized Medicine and Unlock Discoveries Across Cardiology, Mental and Reproductive Health, Drug Response, Cancer Research and Rare Diseases MENLO PARK, Calif. -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced that the University of Tartu, host of Estonia's National Biobank, has chosen the [...]
THE NEW OV 725 DIGITAL DISPERSER: ACHIEVE MORE, EXPERIENCE MORE
March 27, 2024
Introducing the new OV 725 Digital: your ultimate solution for dispersion, homogenization, and mixing challenges. Engineered for matching a wide range of applications, ensuring accurate performance, effortless operations and lasting durability to your lab. Looking to take your homogenizing experience to the next level? Look no further than the OV 725 Digital! Engineered to meet the evolving needs of diverse [...]
Sartorius and LFB BIOMANUFACTURING collaborate on cell line development and manufacturing
March 27, 2024
LFB BIOMANUFACTURING will outsource cell line development service to Sartorius to combine the best of each company’s expertise and increase value for customers Collaboration provides single-stop solution for customers to speed up protein therapy development LFB BIOMANUFACTURING specializes in therapeutic protein biomanufacturing, and is an entity of LFB, a leading European company providing plasma-derived medicinal [...]
Xcell Biosciences Announces New Scientific and Business Advisory Board
March 27, 2024
Advisors will support the company’s ongoing expansion of its technology for cell and gene therapy applications SAN FRANCISCO -- Xcell Biosciences Inc. (Xcellbio), an instrumentation company focused on cell and gene therapy applications, today announced the formation of a new scientific and business advisory board composed of some of the leading minds in the industry. The board [...]
March 27, 2024
EditCo is focused on the development and manufacture of highly optimized CRISPR guide RNA designs and edited cells for the global cell biology and gene therapy research markets REDWOOD CITY, CA – EditCo Bio, Inc. announced that it has launched its business with the acquisition of Synthego’s engineered cell solutions and enhanced guide RNA business. Borne [...]
Synthego Announces CEO Transition to Focus on Enabling CRISPR Therapeutics
March 27, 2024
Leadership change simultaneous to the Eclipse Cell Engineering platform spinout as EditCo Bio REDWOOD CITY, CA – Synthego Corporation, a leading provider of genome engineering solutions, announced that Paul Dabrowski will step down as Chief Executive Officer, effective immediately. Craig Christianson has been appointed Chief Executive Officer following an extensive search process. Mr. Dabrowski, a [...]
Integrated DNA Technologies Unveils New Custom Vector Onboarding Tool to Optimize Gene Synthesis
March 27, 2024
CORALVILLE, Iowa — Global genomics solutions provider Integrated DNA Technologies (IDT) is expanding its gene synthesis offerings with a new custom vector onboarding tool. The easy-to-use solution is designed for researchers who want to skip in-house cloning steps and move quickly into functional studies with 100% sequence-verified clonal DNA. By using IDT’s new gene synthesis custom [...]
March 27, 2024
North Carolina Collaboratory’s purchase of mass spectrometry instruments from Thermo Fisher Scientific will strengthen PFAS research capacity in service to the State WILMINGTON, N.C. – The North Carolina Collaboratory – an organization dedicated to advancing scientific research for policymaking within North Carolina – today announced its partnership with Thermo Fisher Scientific to advance the State’s [...]
March 27, 2024
BRISTOL, Pa. -- Abzena, the leading end-to-end integrated CDMO for complex biologics and bioconjugates, announced a significant expansion of their Bristol, PA bioconjugate development and cGMP manufacturing site. The $5 million investment in expanded laboratory space, new equipment, and facility upgrades, builds upon the site's existing bioconjugation capabilities and increases capacity to support the delivery of fully integrated biopharmaceutical drug programs. This [...]
March 26, 2024
PACe supports a seamless transition of compatible PAC instruments into an integrated digital platform. HOUSTON, TEXAS -- PAC, a global leader in the manufacture of analytical instrumentation, proudly introduces PACe – a cloud-based digital platform designed to connect compatible PAC instruments. This platform provides customers with real-time insights to help drive efficient decisions regarding asset [...]

